Forcyte Biotechnologies, Inc. STTR Phase I Award, September 2021
A STTR Phase I contract was awarded to Forcyte Biotechnologies in September, 2021 for $350,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like Forcyte Biotechnologies, Inc. STTR Phase I Award, September 2021
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.